Wood Mackenzie Senior Vice President Gregg Karlberg will deliver the talk, entitled "Medicare or MediSCARE?"
to an audience of PBIRG members, including executives at industry-leading organizations.The presentation will focus on how the new Medicare law will affect pharma and biotech firms, whose reimbursement arrangements for drugs and equipment will be impacted by the new legislation.
"So much of what we read about the new Medicare rules addresses its effects on consumers, which is essential - but it is one side of the coin," notes Karlberg
."PBIRG, with the help of Wood Mackenzie's experts, is offering a look at the other side of the same coin: how companies that make the drugs on which so many people depend will adjust to the new healthcare world order."
Karlberg's talk will focus on the key challenges companies will face as the rules come into play, offering potential solutions for confronting those challenges.The presentation will draw on Wood Mackenzie's
research findings, as well as insights based on client case studies. As the head of Wood Mackenzie's Life Sciences consulting practice, Gregg Karlberg provides strategic advice and insight to the world's leading pharmaceutical and biotechnology companies.His
broad consulting background includes more than 25 years of experience helping clients solve mission-critical business issues.